News

Did you know that Summit Therapeutics (NASDAQ: SMMT) is one of the few publicly traded companies that has a market cap of more than $10 billion, but no revenue? With that kind of a valuation and

Sometimes, everything can seem to be going your way. And then the wheels fall off. That's the situation Summit Therapeutics (NASDAQ: SMMT) finds itself in.

Shares of the clinical-stage biotech

It's not possible to go back in time and invest in Nvidia or Amazon when they were still relatively small companies. However, it is possible to identify corporations that appear poised to establish

The wave of crypto optimism we've seen this year hasn't done much for Cardano (CRYPTO: ADA). The smart contract crypto's price is down 50% year over year and, at $0.41, is worth about 86% less than

AstraZeneca (NASDAQ: AZN) stock finished the trading week in style, rising by nearly 3% in value on Friday. That was due to news from the company that it's expanding its manufacturing footprint in

Ten years go by quickly. Duke University professors Chris Monroe and Jungang Kim founded IonQ (NYSE: IONQ) in 2015. Their goal was to develop a commercially viable quantum computer. They succeeded.

Good news from the laboratory put some zip into AstraZeneca (NASDAQ: AZN) shares on Monday. The veteran pharmaceutical company's shares enjoyed a nearly 3% lift across the trading session as a

The U.S. stock market turned sharply lower Tuesday morning in reaction to seemingly negative comments by the CEOs of Morgan Stanley (NYSE: MS) and Goldman Sachs (NYSE: GS). At the Global Financial

Veteran pharmaceutical company AstraZeneca (NASDAQ: AZN) delivered for investors on the second-to-last trading day of the week. Its shares rose by more than 3% across that trading session, thanks

Buying dividend stocks at low prices can have two positive benefits. The first is that if you're buying low, the yield can be higher than normal. It can provide you with some high dividend income

AST SpaceMobile (NASDAQ: ASTS) is on a mission to eliminate dead zones through direct-to-smartphone satellite technology. Its partnerships with telecom giants like AT&T and Vodafone and its massive

What if you had invested in any of the current leaders in the biotech industry before they established themselves as such? You'd have earned terrific returns. While we can't go back in time to do

Explore the exciting world of Summit Therapeutics (NASDAQ: SMMT) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights

AT&T (NYSE: T) is the third-largest wireless carrier in the U.S., serving over 90 million customers. Wireless generates the majority of the company's roughly $120 billion in annual revenue. AT&T

Telecom giant AT&T (NYSE: T) has a simple growth strategy: Win high-value customers who use its wireless and fiber services together. The company picked up plenty of those so-called "converged"

In 2022 and 2023, rising interest rates drove many income investors to sell their dividend stocks and buy risk-free CDs and T-bills for higher yields. But as interest rates decline again, many of

Investing in pharmaceutical stocks can carry risks. It's not always clear which drugs will be successful and turn into blockbusters for their respective businesses. As a result, it can take years

Summit Financial Wealth Advisors, LLC initiated a new position in First Trust Enhanced Short Maturity ETF (NASDAQ:FTSM), acquiring approximately $20.03 million in shares as of Q3 2025, according to

Even in hindsight, it would have been difficult to predict Summit Therapeutics' (NASDAQ: SMMT) exceptional rise over the past three years. The company's shares have skyrocketed by more than 1,500%

St. Louis Financial Planners Asset Management, LLC disclosed in a Thursday filing with the SEC that it sold shares of AT&T worth an estimated $3.3 million in the third quarter.

According to a

Summit Financial Wealth Advisors, LLC established a new position in Lockheed Martin(NYSE:LMT), acquiring 12,393 shares valued at approximately $5.74 million as of the second quarter ended June 30

Share price has nothing to do with whether a stock is fairly valued. However, it is nonetheless an important consideration for investors on tight budgets. 

With that in mind, three Fool.com

Investors cannot get enough of space economy stocks. Upstarts such as AST SpaceMobile (NASDAQ: ASTS) are seeing soaring stock prices, with AST SpaceMobile stock going from a low of around $2 in 2024

If you're in retirement or simply want some dividend income to rely on, it's important to focus on stocks that have strong financials and that may potentially boost their payouts in the future. The

KalVista Pharmaceuticals (NASDAQ:KALV), a biopharmaceutical company developing and commercializing therapies for rare diseases, announced its earnings for the first quarter of fiscal 2026 on Sept